Nylia 7/7 /7 is a hormonal birth control pill which is used to prevent pregnancy. The drug contains two hormones – ethinyl estradiol and norethindrone
- Pregnancy prevention.
Nylia 7/7 /7 works by blocking ovulation, slowing the release of the egg in the ovary.
Each pack contains 28 tablets:
- 7 white tablets each containing 0.5 mg of norethindrone and 0.035 mg of ethinyl estradiol;
- 7 light peach tablets each containing 0.75 mg of norethindrone and 0.035 mg of ethinyl estradiol;
- 7 peach tablets each containing 1 mg of norethindrone and 0.035 mg of ethinyl estradiol;
- 7 green tablets containing only inert ingredients.
Tablets should be swallowed whole, with water.
Started using the drug either on the first day of your menstrual bleeding or on the first Sunday following the onset of your menstrual bleeding. If you are a Sunday starter, you should use a non-hormonal method of birth control the first 7 days (during the first cycle of Nylia 7/7 /7).
Cases of overdose have not been reported. Potential adverse reactions include a headache, vomiting, nausea, vaginal discharge. If you have any severe reactions after taking a high dose of the drug, seek emergency medical attention.
The drug causes side effects rarely. Potential adverse reactions include but are not limited to:
- blood clots;
- a stroke;
- leg pain;
- a severe headache;
- liver tumors;
- high blood pressure;
- gallbladder disease;
- vaginal infections;
- breast cancer;
- vision disorders, temporary blindness;
- chest pain;
- weight gain;
- shortness of breath;
- cervical cancer;
- painful menses;
- mood changes;
- breast enlargement;
- nipple pain;
- breast tenderness;
- breast pain;
- pain discomfort.
If you have any severe negative reactions after taking Nylia 7/7 /7 tablets, seek emergency medical care.
Do not use this contraceptive if you have any of the following contraindications for use:
- hypersensitivity to ethinyl estradiol or norethindrone;
- age over 35 and smoking;
- cerebrovascular disease;
- migraine headaches;
- liver tumors, liver disease;
- coronary artery disease;
- use of ombitasvir/paritaprevir/ritonavir, with or without dasabuvir;
- uncontrolled hypertension;
- diabetes mellitus with vascular disease;
- headaches with focal neurological symptoms;
- thrombogenic diseases of the heart;
- breast cancer or other estrogen- or progestin-sensitive cancer (including a history);
- abnormal uterine bleeding.
Do not take Nylia 7/7 /7 tablets if you currently have any of the following medications:
- tranexamic acid;
- St. John’s wort.
Before using any of the listed drugs, bu sure to inform your doctor that you are on birth control pills.
Do not use Nylia 7/7 /7 during pregnancy since there is no reason for that. Do not use COCs in breastfeeding period because the active ingredients can get into the breast milk and negatively affect the child.
If you miss one active tablet in Weeks 1, 2, or 3, take it as soon as possible. If you miss two active tablets in Week 1 or Week 2, take two tablets the day you remembers and two tablets the next day; then keep taking one tablet per day until the pack is empty. Use an additional non-hormonal method of contraception if you have sex in the seven days after missing the tablets. If you miss two active tablets in the Week 3 or miss three or more active tablets in a row, you should discard the remaining tablets and start a new pack that same day. Use an additional non-hormonal method of contraception if you have sexual intercourse in the seven days after missing the tablets.
If you have diseases of the cardiovascular system such as venous and arterial thrombosis and thromboembolism (deep vein thrombosis, pulmonary embolism, myocardial infarction, stroke), you must consult a doctor prior to taking Nylia 7/7 /7 tablets. A consultation is also required if these conditions develop for the first time.
Use the drug with caution if you have any of the following conditions:
- age over 35;
- heart disease;
- predisposition to venous or arterial thromboembolism;
- excessive smoking
- severe migraine headaches;
- you are expecting an extensive surgery.
In rare cases, COCs may increase the risk of cervical cancer. The increased risk gradually disappears within 10 years after discontinuation of these medications.
In very rare cases, COCs caused benign or malignant tumors of the liver.
Women with hypertriglyceridemia or a predisposition to it may have an increased risk of pancreatitis while taking combination oral contraceptives.
The drug may increase blood pressure but clinically significant increases are rare.
Women with a predisposition to angioedema have an increased risk of this condition.
COCs may change insulin resistance and glucose tolerance.
Women with who had chloasma during pregnancy may have an increased risk of chloasma development.
The drug may change the results of some laboratory tests (liver function, kidney, thyroid, adrenal glands, proteins in the blood plasma, clotting parameters and others).
Missing active tablets, gastrointestinal disorders, and some drugs may reduce the effectiveness of Nylia 7/7 /7.
Woman using COCs may have irregular vaginal bleeding (especially during the first three months of use). Typically, this bleeding disappears when the body gets used to the hormones. If you irregular bleeding after the adaptation period, consult a doctor in order to exclude tumors or pregnancy.
You may miss your period. If the drug was used correctly, the risk of pregnancy is very small. However, if you missed active tablets or have no periods in a row, consult a doctor in order to exclude pregnancy.
Before using Nylia 7/7 /7 for birth control. You need to consult a doctor and undergo a thorough medical examination. Catch-up examinations are needed once in 6 months.
COCs do not protect against sexually transmitted diseases.
If you are expecting a long-term immobilization, you need to stop using birth control pills at least 4 weeks before the planned surgery).
The medication does not affect the ability to drive a car and manage mechanisms.
Discard the tablets after the expiration date.
Store the drug at room temperature, away from light, heat and moisture, out of the reach of children.